Publications by authors named "Yang-si Li"

Claim this Profile
C
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa.
Kun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, Xiao-Xi Wang, Yan-Zhen Lai, Xue-Ling Wei, Qiu-Ming Li, Yang-Si Li

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
Kun-Peng Wu, Xu-Qiang Luo, Qing-Qing Li, Hong-Cheng Yang, Mei-Chen Ji, Yun Li, Yang-Si Li

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.
Yang-Si Li, Wenpu Lai, Kai Yin, Hai-Yan Tu, Liang Li, Shou-Heng Lin, Peng Li, Si-Yang Maggie Liu, Yangqiu Li

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Yang-Si Li, Qitao Yu, Qing Bu, Lizhu Lin, Fangling Ning, Gen Lin, Shenglin Ma, Anwen Liu, Cailian Wang, Si-Yang Maggie Liu

J Thorac Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System Disease.
Chang Lu, Hong-Hong Yan, Chan-Yuan Zhang, Shi-Yuan Chen, Yang-Si Li

Clin Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, Ben-Yuan Jiang, Li-Bo Tang, Guang-Ling Jie, Si-Yang Liu, Su-Yun Li, Si-Yang Maggie Liu, Shang-Li Cai, Yang-Si Li

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAI-1-driven SFRP2 cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy.
Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, Zi-Xuan Rong, Yuan Fang, Le-Yi Lin, Yang-Si Li, Yan Lin, Li Liu

Cancer Cell· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma.
Jia-Xin Lin, Kai Yin, Li-Xu Yan, Mei-Mei Zheng, Yang-Si Li, Shi-Ling Zhang, Qing-Ling Zhang

JTO Clin Res Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC.
Yang-Si Li, Wen-Pu Lai, Kai Yin, Mei-Mei Zheng, Hai-Yan Tu, Liang Li, Shou-Heng Lin, Yue-Li Sun, Jia-Xin Lin, Si-Yang Maggie Liu, Yangqiu Li

Cell Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Song Dong, Zhen Wang, Jia-Tao Zhang, Bingfa Yan, Chao Zhang, Yang-Si Li, Si-Yang Maggie Liu, Ri-Qiang Liao, Jun-Tao Lin, An-Na Li, Si-Yang Liu

JAMA Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, Ben-Yuan Jiang, Li-Xu Yan, Ze-Dao Liu, Li-Shan Peng, Si-Qi Li, Yang-Si Li, Ri-Qiang Liao

Cell Rep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Si-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, Chong-Rui Xu, Hong-Hong Yan, Yang-Si Li, Jia-Xin Lin, Yangqiu Li

Sci Bull (Beijing)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and dose selection of AZD3759 in patients with untreated -mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, Yingying Du, Jiu-Wei Cui, Yang-Si Li, Anna Li, Yue-Li Sun

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.
Hai-Yan Tu, Kai Yin, Xiaotian Zhao, E-E Ke, Si-Pei Wu, Yang-Si Li, Si-Yang Maggie Liu, Yue-Li Sun, Jia-Xin Lin, Lingling Yang

Mol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial.
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, Hong-Hong Yan, Xiao-Rong Dong, Yang-Si Li, An-Na Li, Yue-Li Sun, Jia-Xin Lin, Yangqiu Li

Nat Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.
Yang-Si Li, Guang-Ling Jie, Yi-Long Wu

Ther Adv Med Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
Mei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, Hao Sun, Kai Yin

BMC Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
Hai-Yan Tu, Yang-Si Li, Xiao-Yan Bai, Yue-Li Sun, Ming-Ying Zheng, Ri-Qiang Liao, Jia-Xin Lin, Xiaoling Tong

Clin Lung Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal Pemetrexed: Another Potential Treatment Modality for Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases?
Mei-Mei Zheng, Yang-Si Li, Hao Sun, Hua-Jun Chen, Yi-Long Wu

J Thorac Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments.
Mei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Yang-Si Li

Eur J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report.
Hai-Yan Tu, Yang-Si Li, Jin-Ji Yang, Hua-Jun Chen, Ben-Yuan Jiang

Clin Drug Investig· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC.
Mei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, Ben-Yuan Jiang, Jin-Ji Yang

J Thorac Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib Leads the Way Toward Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal Metastases.
Mei-Mei Zheng, Yang-Si Li, Hao Sun, Yi-Long Wu

J Thorac Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
Yang-Si Li, Mei-Mei Zheng, Ben-Yuan Jiang, Hai-Yan Tu, Jin-Ji Yang

JAMA Netw Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
Kai Yin, Yang-Si Li, Mei-Mei Zheng, Ben-Yuan Jiang, Wen-Feng Li, Lin-Lin Li

Lung Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis